These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 30833898)
1. An Tanner L; Haynes RK; Wiesner L Front Pharmacol; 2019; 10():120. PubMed ID: 30833898 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
4. Elucidating the Antimycobacterial Mechanism of Action of Decoquinate Derivative RMB041 Using Metabolomics. Knoll KE; Lindeque Z; Adeniji AA; Oosthuizen CB; Lall N; Loots DT Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34200519 [TBL] [Abstract][Full Text] [Related]
5. Knoll KE; van der Walt MM; Loots DT Microbiol Spectr; 2022 Apr; 10(2):e0231521. PubMed ID: 35352998 [TBL] [Abstract][Full Text] [Related]
6. The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria. Watson DJ; Laing L; Beteck RM; Gibhard L; Haynes RK; Wiesner L Front Pharmacol; 2022; 13():957690. PubMed ID: 36091789 [TBL] [Abstract][Full Text] [Related]
7. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms. Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059 [TBL] [Abstract][Full Text] [Related]
8. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of TB-Active Compounds in Murine Organs Relevant to Infection by Tanner L; Haynes RK; Wiesner L Front Pharmacol; 2020; 11():724. PubMed ID: 32508649 [TBL] [Abstract][Full Text] [Related]
14. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
15. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis. Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685 [TBL] [Abstract][Full Text] [Related]
16. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren. Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296 [TBL] [Abstract][Full Text] [Related]
17. [Prospects for development of new antituberculous drugs]. Tomioka H Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis. Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981 [TBL] [Abstract][Full Text] [Related]
19. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]